🦠 #INCATE, co-founded by #DZIF, awards Swiss start-up #PhalconBio €250,000 to advance preclinical development of an inhaled phage therapy for ventilator-associated pneumonia.

👉 Read more: t1p.de/0agp5

#AMR #PhageTherapy @incate.bsky.social

🦠 A clearer picture of microbial communities: Metax, a new taxonomic profiler developed at #HZI with #DZIF scientists, improves the reliable detection of microbial signatures.

👉 Read more: t1p.de/jjnqy

#Microbiome #Microbiology @helmholtzhzi.bsky.social

A new way to target drug-resistant #tuberculosis: An international team including #DZIF scientists has shown how the natural compound #corramycin targets DNA gyrase and why it remains effective against fluoroquinolone-resistant bacteria.

👉 Read more: t1p.de/t7m2a

#TB #DrugDevelopment

Interesting read 🤓👇 The PROTON project, led by #DZIF scientist Mark Brönstrup, is substantially supported by the #DZIF and its Product Development Unit 🥳

How can personalized #phage therapy be applied safely and consistently in clinical practice? A new #guideline covers key aspects like phage selection, quality control and clinical use. 👉 t1p.de/kocwc
@dgfi-org.bsky.social #DZIF @awmf.bsky.social @uniklinikkoeln.bsky.social @goetheuni.bsky.social